Allegra Medical Technologies (AMT.AX) Stock Price
Allegra Medical Technologies Price
Revenue at Allegra Medical Technologies has contracted by 45.5% per year over the past 18 years to 100.00 AUD. Earnings per share have declined at 0.5% per year over the last 12 years. Allegra Medical Technologies's net margin stands at -3,647,700.0%, down from -12.9% several years earlier.
Allegra Medical Technologies stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Allegra Medical Technologies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Allegra Medical Technologies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Allegra Medical Technologies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Allegra Medical Technologies Price |
|---|
Allegra Medical Technologies Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Allegra Medical Technologies Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| SHARESM |
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.00 | 6.00 | 7.00 | 7.00 | 8.00 | 7.00 | 7.00 | 7.00 | 5.00 | 4.00 | 4.00 | 3.00 | 5.00 | 4.00 | – | – |
| 40.00 | -14.29 | 16.67 | – | 14.29 | -12.50 | – | – | -28.57 | -20.00 | – | -25.00 | 66.67 | -20.00 | – | – |
| 57.14 | 50.00 | 57.14 | 57.14 | 62.50 | 42.86 | 57.14 | 42.86 | 40.00 | 75.00 | 75.00 | 66.67 | 40.00 | 50.00 | – | – |
| 4.00 | 3.00 | 4.00 | 4.00 | 5.00 | 3.00 | 4.00 | 3.00 | 2.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| – | -1.00 | – | -2.00 | – | – | – | -1.00 | -1.00 | – | – | – | -1.00 | – | -1.00 | -1.00 |
| – | -16.67 | – | -28.57 | – | – | – | -14.29 | -20.00 | – | – | – | -20.00 | – | – | – |
| – | -1.00 | – | -3.00 | – | – | – | – | -2.00 | – | – | – | -1.00 | – | -2.00 | -3.00 |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 50.00 |
| 37.97 | 38.79 | 38.79 | 38.79 | 38.79 | 42.22 | 48.08 | 61.16 | 67.88 | 75.67 | 94.25 | 99.56 | 99.56 | 104.37 | 104.46 | 104.46 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Allegra Medical Technologies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Allegra Medical Technologies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Allegra Medical Technologies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Allegra Medical Technologies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Allegra Medical Technologies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Allegra Medical Technologies stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Allegra Medical Technologies Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Allegra Medical Technologies business model & stock analysis
Allegra Medical Technologies SWOT Analysis
Strengths
Allegra Orthopaedics Ltd has a strong reputation in the market for producing high-quality orthopaedic products. The company's products are recognized for their superior design, durability, and effectiveness in addressing various orthopaedic issues.
Allegra Orthopaedics Ltd has a robust research and development (R&D) team that continuously innovates and enhances its product line. This gives the company a competitive edge by staying ahead of market trends and meeting the evolving needs of customers.
The company has established strong relationships with key healthcare professionals, including surgeons, hospitals, and medical practitioners. These relationships enable Allegra Orthopaedics Ltd to gain valuable insights, collaborate on product development, and drive sales through referrals and recommendations.
Weaknesses
One of the weaknesses of Allegra Orthopaedics Ltd is its limited geographical presence. The company's operations are currently concentrated in a few regions, which restricts its market reach and growth opportunities. Expanding into new markets can be a challenge due to regulatory complexities and the need to establish local distribution networks.
Allegra Orthopaedics Ltd is not as well-known compared to some of its larger competitors. Limited brand awareness may hinder its ability to attract new customers and gain market share, especially in highly competitive markets.
The company's heavy reliance on third-party suppliers for raw materials and components poses a risk to its supply chain. Any disruptions or quality issues with suppliers can negatively impact production and lead to delays in product delivery.
Opportunities
The growing aging population worldwide presents a significant opportunity for Allegra Orthopaedics Ltd. As the elderly population increases, there will be a higher demand for orthopaedic products and surgical procedures. By targeting this demographic, the company can potentially tap into a large and growing market segment.
Expanding into emerging markets, such as Asia-Pacific and Latin America, can provide Allegra Orthopaedics Ltd with new growth opportunities. These regions have a rising demand for advanced orthopaedic solutions, and entering these markets early can establish a strong foothold and access a large customer base.
Technological advancements in orthopaedics, such as robotics-assisted surgery and 3D-printed implants, present opportunities for Allegra Orthopaedics Ltd to develop innovative products and stay at the forefront of the industry. Embracing these advancements can differentiate the company and attract tech-savvy customers.
Threats
Intense competition from established orthopaedic companies poses a threat to Allegra Orthopaedics Ltd. Competitors with greater financial resources and market presence can outspend on marketing, research, and development, which may put pressure on the company's market share.
Regulatory challenges and compliance requirements in the healthcare industry can pose risks to Allegra Orthopaedics Ltd. Changing regulations, product approvals, and compliance with quality standards can increase costs and delay product launches.
External factors, such as economic downturns or global pandemics, can impact the demand for orthopaedic products and affect the company's financial performance. Uncertainties in the healthcare industry and reimbursement policies can create instability in the market and affect Allegra Orthopaedics Ltd's revenue streams.
Allegra Medical Technologies Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Allegra Medical Technologies historical P/E ratio, EBIT multiple, and P/S ratio
Allegra Medical Technologies annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Allegra Medical Technologies shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Allegra Medical Technologies shareholder structure
| % | Name |
|---|---|
91.39298% | |
0.17671% | |
0.00000% |
Allegra Medical Technologies Beneficial Ownership Filings (SEC 13D/G)
Allegra Medical Technologies Executives and Management Board
5 members · 40 % women
Ms. Jenny Swain
Chief Executive Officer
345,423.00 AUD
Management
Ms. Robyn Slaughter
Company Secretary
Board of Directors
Mr. Peter Kazacos
Independent Non-Executive Chairman of the Board
Mr. Sean Mulhearn
Non-Executive Independent Director
Dr. Nicholas Hartnell
Non-Executive Director
Allegra Medical Technologies Supply Chain
Allegra Medical Technologies Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.67 | 0.36 | — |
Frequently asked questions about Allegra Medical Technologies
The business model of Allegra Orthopaedics Ltd revolves around developing and commercializing innovative orthopedic implants and surgical instruments. With a focus on the extremities market, the company aims to provide solutions for a wide range of orthopedic conditions and injuries. Allegra Orthopaedics leverages its expertise in research and development to design and manufacture high-quality, patient-specific implants that offer improved surgical outcomes. By collaborating with surgeons and healthcare professionals, the company strives to address unmet needs in the orthopedic industry and enhance patient care. Allegra Orthopaedics Ltd is dedicated to delivering innovative orthopedic solutions, contributing to the advancement of orthopedic surgery.
Allegra Orthopaedics Ltd is primarily active in the healthcare industry, specifically specializing in the field of orthopedics.
The main competitors of Allegra Orthopaedics Ltd in the market include established orthopedic companies such as Johnson & Johnson's DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings Inc., and Medtronic plc. These companies also specialize in manufacturing and supplying orthopedic devices and implants.
Allegra Orthopaedics Ltd is an Australian-based company specializing in the design, development, and distribution of innovative orthopedic implant solutions. Established in 2014, Allegra Orthopaedics focuses on developing implants that provide better patient outcomes and improve surgical techniques. The company's commitment to research and development has led to the introduction of innovative products tailored to the needs of surgeons and patients. With a team of experienced professionals and strategic partnerships, Allegra Orthopaedics aims to improve the quality of life for individuals requiring orthopedic interventions.
Allegra Orthopaedics Ltd has achieved several significant milestones since its establishment. The company has successfully developed and launched innovative orthopedic solutions, providing efficient and reliable treatments for various musculoskeletal conditions. Additionally, Allegra Orthopaedics Ltd has gained regulatory approvals and certifications for its products, ensuring their quality and safety. The company has also established strategic partnerships and collaborations with renowned healthcare institutions, enabling it to expand its market reach and enhance its research and development capabilities. Furthermore, Allegra Orthopaedics Ltd has achieved remarkable financial growth and recognition within the orthopedic industry, solidifying its position as a leading provider of orthopedic solutions.
Allegra Orthopaedics Ltd is primarily present in Australia and New Zealand.
Allegra Orthopaedics Ltd represents a strong commitment to providing innovative orthopaedic solutions. The company's corporate philosophy revolves around delivering superior patient outcomes, fostering collaborative partnerships, and embracing technological advancements in orthopaedic care. With a focus on research and development, Allegra Orthopaedics strives to introduce cutting-edge products and surgical techniques that enhance patient mobility and quality of life. As a leader in the orthopaedic industry, Allegra Orthopaedics is dedicated to maintaining the highest standards of integrity, professionalism, and customer satisfaction.
Converted at the current exchange rate, the Allegra Medical Technologies share trades at 0.02 EUR (0.03 AUD).
The Allegra Medical Technologies share (AMT.AX) is listed on 1 stock exchanges, including: ASX (AMT.AX).
The company Allegra Orthopaedics Ltd is a medical company specializing in the development, manufacturing, and distribution of innovative orthopedic implants. Its goal is to improve the quality of life for patients by offering top-notch solutions for orthopedic problems. The company is headquartered in Australia and operates in other countries such as the USA, Europe, and Asia.
The revenue cannot currently be calculated for Allegra Medical Technologies.
The profit cannot currently be calculated for Allegra Medical Technologies.
The P/E ratio cannot be calculated for Allegra Medical Technologies at the moment.
The P/S cannot be calculated for Allegra Medical Technologies currently.
The Eulerpool Quality Score for Allegra Medical Technologies is 1/10.
The ISIN of Allegra Medical Technologies is AU000000AMT8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Allegra Medical Technologies is A0M7NQ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Allegra Medical Technologies is AMT.AX. The ticker symbol is used to trade Allegra Medical Technologies shares on the stock exchange.
Allegra Medical Technologies paid dividends every year for the past 0 years.
Allegra Medical Technologies is assigned to the 'Health' sector.
The dividends of Allegra Medical Technologies are distributed in AUD.
Allegra Medical Technologies stock
Allegra Medical Technologies Peer Group
Allegra Medical Technologies Ticker
Allegra Medical Technologies FIGI
All fundamentals and in-depth analysis of Allegra Medical Technologies
Our stock analysis for Allegra Medical Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Allegra Medical Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.